Search Result "Imatinib mesylate"


Medical Treatment of Gastrointestinal Stromal Tumors: State of the Art and Future Perspectives

Journal: Reviews on Recent Clinical Trials
Volume: 1 Issue: 1 Year: 2006 Page: 35-42
Author(s): Gaetano Apice, Amalia Milano, Giovanni S. Bruni, Rosario V. Iaffaioli, Francesco Caponigro

Critical Update and Emerging Trends in Imatinib Treatment for Gastrointestinal Stromal Tumor

Journal: Reviews on Recent Clinical Trials
Volume: 2 Issue: 1 Year: 2007 Page: 43-48
Author(s): Ugo De Giorgi, Alberto Pupi, Gina Turrisi, Iolanda Montenora, Stefano Morini, Mozghan Fayyaz, Michele De Simone, Giammaria Fiorentini

The Kinase Inhibitor Imatinib - An Immunosuppressive Drug?

Journal: Current Cancer Drug Targets
Volume: 7 Issue: 3 Year: 2007 Page: 251-258
Author(s): D. Wolf, H. Tilg, H. Rumpold, G. Gastl, A. M. Wolf

Nuclear Translocation of Heme Oxygenase-1 Confers Resistance to Imatinib in Chronic Myeloid Leukemia Cells

Journal: Current Pharmaceutical Design
Volume: 19 Issue: 1 Year: 2013 Page: 2765-2770
Author(s): Daniele Tibullo, Ignazio Barbagallo, Cesarina Giallongo, Piera La Cava, Nunziatina Parrinello, Luca Vanella, Fabio Stagno, Giuseppe A. Palumbo, Giovanni Li Volti, Francesco Di Raimondo

Resistance to Imatinib in Chronic Myeloid Leukemia and Therapeutic Approaches to Circumvent the Problem

Journal: Cardiovascular & Hematological Disorders-Drug Targets
Volume: 9 Issue: 1 Year: 2009 Page: 21-28
Author(s): Massimo Breccia, Giuliana Alimena

Research Article

Encapsulation of Imatinib in Targeted KIT-5 Nanoparticles for Reducing its Cardiotoxicity and Hepatotoxicity

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 20 Issue: 1 Year: 2020 Page: 1966-1980
Author(s): Jaleh Varshosaz,Saeedeh Fardshouraki,Mina Mirian,Leila Safaeian,Setareh Jandaghian,Somayeh Taymouri

Second Generation Abl Kinase Inhibitors and Novel Compounds to Eliminate the Bcr-Abl/T315I Clone

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 1 Issue: 3 Year: 2006 Page: 347-355
Author(s): Shinya Kimura

Basis for Resistance to Imatinib in 16 BCR-ABL Mutants as Determined Using Molecular Dynamics

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 4 Issue: 2 Year: 2009 Page: 164-173
Author(s): Tai-Sung Lee, Steven J. Potts, Maher Albitar

Imatinib Dosing in Gastrointestinal Stromal Tumors (GISTs): When, How Much, and How Long?

Journal: Current Clinical Pharmacology
Volume: 10 Issue: 4 Year: 2015 Page: 311-320
Author(s): Mohammed Milhem,Jeremy M. Deutsch

Targeting the Kinase Activity of the BCR-ABL Fusion Protein in Patients with Chronic Myeloid Leukemia

Journal: Current Molecular Medicine
Volume: 5 Issue: 7 Year: 2005 Page: 615-623
Author(s): Francis J. Giles, Jorge E. Cortes, Hagop M. Kantarjian

Previous   Next

Go To   Results 11 - 20 of 684

Filter Result

Volume Year
Content Type
Ads
© 2024 Bentham Science Publishers | Privacy Policy